Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus Vaccines”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Early research (Phase 1)Study completedNCT02374385
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

Who this might be right for
Ebola Viruses
Dalhousie University 40
Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Testing effectiveness (Phase 2)Study completedNCT02287480
What this trial is testing

VSV-ZEBOV Geneva Vaccine Trial

Who this might be right for
Ebolavirus Disease
University Hospital, Geneva 115
Post-approval studies (Phase 4)Looking for participantsNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Early research (Phase 1)Study completedNCT04041570
What this trial is testing

Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Early research (Phase 1)Study completedNCT02280408
What this trial is testing

Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)

Who this might be right for
Ebola Viruses
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Early research (Phase 1)Study completedNCT02408913
What this trial is testing

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 140
Early research (Phase 1)UnknownNCT02296983
What this trial is testing

Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Testing effectiveness (Phase 2)Study completedNCT04186000
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Who this might be right for
Ebola Virus Disease
Universiteit Antwerpen 699
Not applicableStudy completedNCT03098862
What this trial is testing

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,830
Large-scale testing (Phase 3)Study completedNCT02378753
What this trial is testing

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Who this might be right for
Hemorrhagic Fever, Ebola
Centers for Disease Control and Prevention 8,651
Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)UnknownNCT04152486
What this trial is testing

Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 20,426
Load More Results